Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt

Arms (0)

Primary outcomes (2)

1. measure

   Overall survival (OS)

   timeFrame

   From date of treatment initiation until the date of death from any cause or patients censored at last follow up, whichever came first, assessed up to 60 months

   description

   Participants will be retrospectively followed forward in time from the date of initiation of treatment till death from any cause, an expected average of 5 years

2. measure

   Event Free Survival (EFS)

   timeFrame

   From date of treatment initiation until the date of event from any cause or patients censored at last follow up, whichever came first, assessed up to 60 months

   description

   Participants will be retrospectively followed forward in time from the date of initiation of treatment till occurrence of an event from any cause (tumor progression, relapse) or death, an expected average of 5 years